Teleflex Incorporated

TFX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $152.5M $237.4M $244.9M $187.7M $150.9M $-190.1M $323.3M $201.1M
Depreciation & Amortization $160.3M $128.3M $125.3M $127.0M $107.9M $94.9M $96.5M $89.7M
Depreciation $56.5M $54.4M $46.0M $50.2M $42.4M $36.2M $40.3M $41.2M
Amortization $98.8M $63.5M $62.4M $60.9M $50.6M $44.3M $42.6M $40.8M
Stock-Based Compensation $19.4M $16.9M $14.5M $12.2M $11.9M $8.6M $4.5M $8.5M
Net Cash from Operating Activities $426.3M $410.6M $303.4M $290.2M $231.3M $194.6M $94.4M $143.8M
Investing Activities
Capital Expenditures $70.9M $53.1M $61.4M $67.6M $63.6M $65.4M $44.6M $29.3M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — — —
Financing Activities
Dividends Paid $61.2M $59.0M $56.5M $56.3M $55.9M $55.6M $55.1M $54.3M
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities — — — — — — — $-1.1M
Net Change in Cash $-210.2M $205.4M $35.1M $-128.7M $94.9M $-247.0M $375.6M $20.1M
Free Cash Flow $355.4M $357.5M $242.0M $222.7M $167.7M $129.2M $49.8M $114.5M
← Newer Page 2 of 3 Older →